Literature DB >> 1437923

Systemic lupus erythematosus in 50 year olds.

I Domenech1, O Aydintug, R Cervera, M Khamashta, A Jedryka-Goral, J L Vianna, G R Hughes.   

Abstract

We compared the clinical and serological characteristics of 15 patients with onset of systemic lupus erythematosus after the age of 50 with those of 232 younger patients. The sex distribution was similar in both groups. All 15 patients were Caucasian. Autoimmune thyroiditis was found in 20% of the elderly patients. Initial manifestations, which presented more frequently in the older group, included thrombocytopenia (P < 0.05), sicca syndrome (P < 0.01) and cardiomyopathy (P < 0.005), whereas butterfly rash (P < 0.05) presented more frequently in the younger group. Analysis of cumulative clinical symptoms showed that butterfly rash (P < 0.05) and livedo reticularis (P < 0.05) were less frequent in the elderly. However, this group presented a significantly increased incidence of sicca syndrome (P < 0.005) and cardiomyopathy (P < 0.005). Antibodies to double-stranded DNA tended to occur less frequently in older patients (P < 0.05).

Entities:  

Mesh:

Year:  1992        PMID: 1437923      PMCID: PMC2399336          DOI: 10.1136/pgmj.68.800.440

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  18 in total

Review 1.  Systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

2.  SLE in the elderly--is it really SLE or systemic Sjögren's syndrome?

Authors:  D A Bell
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

Review 3.  Outcome and prognosis in systemic lupus erythematosus.

Authors:  E M Ginzler; K Schorn
Journal:  Rheum Dis Clin North Am       Date:  1988-04       Impact factor: 2.670

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  Systemic lupus erythematosus in the elderly: clinical and immunological characteristics.

Authors:  J Font; L Pallarés; R Cervera; A López-Soto; M Navarro; X Bosch; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

6.  Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.

Authors:  M C Hochberg; R E Boyd; J M Ahearn; F C Arnett; W B Bias; T T Provost; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1985-09       Impact factor: 1.889

7.  A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus.

Authors:  J L Vianna; H J Haga; R A Asherson; G Swana; G R Hughes
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

8.  Late onset systemic lupus erythematosus.

Authors:  S B Baker; J R Rovira; E W Campion; J A Mills
Journal:  Am J Med       Date:  1979-05       Impact factor: 4.965

9.  High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population.

Authors:  M N Manoussakis; A G Tzioufas; M P Silis; P J Pange; J Goudevenos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

10.  Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death.

Authors:  J D Reveille; A Bartolucci; G S Alarcón
Journal:  Arthritis Rheum       Date:  1990-01
View more
  9 in total

Review 1.  Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.

Authors:  Laurent Arnaud; Alexis Mathian; Jacques Boddaert; Zahir Amoura
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

2.  Cell lineage-specific genome-wide DNA methylation analysis of patients with paediatric-onset systemic lupus erythematosus.

Authors:  Kit San Yeung; Tsz Leung Lee; Mo Yin Mok; Christopher Chun Yu Mak; Wanling Yang; Patrick Chun Yin Chong; Pamela Pui Wah Lee; Marco Hok Kung Ho; Sanaa Choufani; Chak Sing Lau; Yu Lung Lau; Rosanna Weksberg; Brian Hon Yin Chung
Journal:  Epigenetics       Date:  2019-03-16       Impact factor: 4.528

Review 3.  Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.

Authors:  Deana Lazaro
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

4.  Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus.

Authors:  Rafael Hennemann Sassi; Jordana Vaz Hendler; Giovana Fagundes Piccoli; Andrese Aline Gasparin; Rafael Mendonça da Silva Chakr; João Carlos Tavares Brenol; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2016-11-17       Impact factor: 2.980

5.  Disease Expression and HLA Types in Early and Late Onset Disease of Malaysian Patients with Systemic Lupus Erythematosus.

Authors:  A M Radzi; K S Huan; N Yahaya; A Shahera; N Kong; R Mohd Noah
Journal:  Malays J Med Sci       Date:  2001-07

Review 6.  Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management.

Authors:  Oshrat E Tayer-Shifman; Kathleen S Bingham; Zahi Touma
Journal:  Drugs Aging       Date:  2021-12-16       Impact factor: 3.923

7.  Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Jennifer L Medlin; Karen E Hansen; Sara S McCoy; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2018-01-31       Impact factor: 5.532

Review 8.  A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus.

Authors:  Jennifer L Medlin; Karen E Hansen; Sara R Fitz; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2016-01-21       Impact factor: 5.532

9.  Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages.

Authors:  Melissa Padovan; Marcello Govoni; Gabriella Castellino; Nicoletta Rizzo; Maria Fotinidi; Francesco Trotta
Journal:  Rheumatol Int       Date:  2006-12-29       Impact factor: 3.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.